Diagnostics Industry Market Research & Statistics

  • Currently 4/5 Stars.
  • 1
  • 2
  • 3
  • 4
  • 5
11 votes

Global DiaThe IVD market, estimated at $44 billion in 2010, is predicted to reach $52 billion by 2013. (Photo: M. Terraza)gnostics Industry


The diagnostics industry involves testing patients to detect disease. Diagnosis can be used in the case of patients already presenting symptoms of disease, to screen asymptomatic patients as a matter of routine, and to allow ongoing testing in patients with disease to establish prognosis or check progress of therapy.


The market can be broadly divided into:

  1. In vitro diagnostics (IVD), which refers to testing samples of blood, tissue, etc;
  2. In vivo diagnostics, which refers to the testing of organ function and tissue, for example electrocardiography; and
  3. Medical imaging, such as x-rays, computerized axial tomography (CAT), mammograms and magnetic resonance imaging (MRI).


Leading Market Segment


The IVD market, estimated at $44 billion in 2010, is predicted to reach $52 billion by 2013 with a compound annual grown rate of approximately 5%, according to research from RNCOS. A particularly profitable growth sector within IVD, molecular diagnostics is predicted to reach $15 billion by 2014 at a compound annual growth rate of just under 20% reports Renub Research. Infectious diseases account for more than a fifth of this segment, followed by oncology testing. By 2014 blood testing and genetic screening together will account for over a quarter of the market, with the US representing $6 billion of the molecular diagnostics market by that time.



Blood grouping reagent Export


Regional Market Share


The IVD market is dominated by the US and the EU, which combined comprise about three quarters of the global market. This is because developed countries are witnessing a proliferation of diet and lifestyle related diseases such as cancer, diabetes and cardiovascular disease, whereas developing countries are more concerned with the diagnosis of infection and infectious disease.


In the lead, the IVD market in the US is forecast to grow 5.4% annually, reaching $23 billion in 2013. According to Global Industry Analysts, the US molecular diagnostics market will be over $6.35 billion by 2015.


Following behind, the EU represents the second-largest regional market, with its infectious-disease testing market estimated to reach $1.02 billion in 2012. There is strong growth in oncology testing and pharmacogenomics, which are predicted to show a compound annual growth rate of 10.71% and 11.05%, respectively, between 2011 and 2015.



Top 3 Diagnostics Players


Roche is the market leader in IVD, holding approximately 20% of total market share, followed by Abbott and Siemens, each holding more than 10%.


  • Roche’s 20% market share represents yearly sales of $44 billion, with key products such as CoaguChek and Accu-Chek fueling the company’s growth. Roche saw 20% growth in Asia-Pacific alone and a 5% rise in the US. Acquisitions, such as in diabetes care (Medingo Ltd) and tissue diagnostics (Biolmagene Inc), should see continued market growth for Roche going forward.


  • In business for over 120 years, Abbott's sales in 2010 reached over $35 billion, and it invested $3.7 billion in R&D. Its main area of expertise in diagnostics is immunodiagnostics. Abbott's immunoassay diagnostic systems, AxSYM, is used to test for cardiovascular disease, cancer, infectious diseases and thyroid conditions.


  • Siemens Diagnostics is the world’s largest clinical diagnostics company, and it launched the first automated standardized direct biomarker panel for liver fibrosis, an indicator of chronic liver disease, in June 2011. The company’s new D-dimer assay for its Stratus CS acute care diagnostic system, approved by the FDA in July 2011, is used in the exclusion of pulmonary embolism. With half a million annual cases of acute pulmonary embolism diagnosed in the US, this 14-minute test with 97% accuracy is poised for substantial market success.



Industry Outlook


Though IVDs currently represent only 2% of healthcare spending according to a report by Roche, it is an industry sector with increasing growth potential as governments are forced to re-evaluate rising healthcare expenses and invest more heavily in diagnostics to emphasize early detection and preventative measures as a less expensive option than curative care.


Diagnostic laboratory testing will also see significant growth: it is predicted to reach $98.4 billion by 2017, says Kalorama Information, largely due to technological innovation, aging populations and increasing demand for esoteric and genetic testing.





Leading Industry Associations


ReportLinker.com offers immediate download access to top market reports & statistics on the Diagnostics Industry from trusted sources.
1-10 of about 1 900 reports

Global Diagnostics Markets

  • January 2014
    12 pages
  • Diagnostics  

  • United States  


View report >

Diagnostics Markets in Europe

  • September 2014
    15 pages
  • Diagnostics  

  • Europe  


View report >

Diagnostics Industry in Asia and India

  • January 2013
    6 pages
  • Diagnostics  



  • Asia  



View report >

Diagnostics Industry in Japan Forecast

  • January 2014
    5 pages
  • Medical Imaging  


  • Japan  

View report >

Diagnostics Industry in France

  • January 2014
    8 pages
  • Diagnostics  

  • France  



View report >

Diagnostics Industry in Germany

  • January 2013
    13 pages
  • Diagnostics  

  • Germany  

View report >

Diagnostics Industry in the UK and India

  • February 2015
    14 pages
  • Diagnostics  

  • United Kingdom  


View report >

Diagnostic Industry in Canada

  • March 2014
    89 pages
  • Diagnostic  

    Biopsy Device  


  • Canada  

View report >

Diagnostic Industry in the US and Brazil

  • January 2014
    9 pages
  • Cardiology  


  • United States  


    South America  

View report >

Search in Diagnostics Industry (About 1 900 reports)
Topics under Diagnostics

Parent industry:  Life Sciences

Related markets: Cancer, Oncology, Medical, Cardiology, Cardiovascular Disease, in Vitro Diagnostic Reagent, Diagnostic, Ultrasound, X-ray, IVD, Pap Smear, in Vitro, Computed Tomography, Microbiology, IN Vitro Instrument, Mammography, Radiography

About 6 200 reports

Purchase Reports From Reputable Market Research Publishers
(From £ 63 - £ 15 040)

2015 Strategies in the Global Clinical Chemistry and Immunodiagnostics Market

2015 Strategies in the Global Clinical Chemistry and Immunodiagnostics Market

  • £ 15 040
  • Industry report
  • May 2015
  • by Venture Planning Group

"2015 Strategies in the Global Clinical Chemistry and Immunodiagnostics Market" is a new seven-country strategic analysis of major business opportunities emerging in the clinical chemistry and immunodiagnostic ...

2015 Strategies In The Global Tumor Marker Testing Mark ...

May 2015 £ 13 504

2015 Strategies In The Global Microbiology Market

May 2015 £ 13 504

2015 Strategies In The Global Hemostasis Diagnostic Tes ...

May 2015 £ 13 504

2015 Strategies In The Global Coagulation Testing Marke ...

May 2015 £ 13 504

2015 Strategies In The Global Transfusion Diagnostic Te ...

May 2015 £ 12 480

Bearing Markets In The World To 2019 - Market Size, Dev ...

April 2015 £ 10 952

2015 Strategies In The Global Hematology And Flow Cytom ...

May 2015 £ 10 176

2015 Strategies In The Global Nucleic Acid Testing Mark ...

May 2015 £ 10 176

2015 Strategies In The European Clinical Chemistry And ...

May 2015 £ 8 192

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.